AbbVie Already Dividend King? Why Apogee Deal Could Cement a Dynasty
AbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
What Does Spx Level Tell You About Market distills the level into actionable insights about market breadth and momentum.
28,520 articlesAbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
GE Vernova’s stock slid after a mixed Q2 report, with earnings missing estimates but revenue beating forecasts. This ...
As February nears its end in 2026, three Schwab ETFs stand out for investors positioning before March. They offer low...
Gas prices are seeping into household budgets and market bets, with analysts warning that the pump’s visibility could...
Investors watched Alphabet slide as news of AI talent exits raised questions about leadership and the pace of AI inve...
Online mattress sales surge in 2026 as shoppers chase value, comfort, and easy returns. This report outlines the tren...
Despite a 2026 pullback, Advanced Micro Devices still shows fundamental strength in data-center AI demand and a diver...
Markets recalibrate after a run by the Magnificent Seven, pushing many to rethink concentration. Three ETFs—RSP, SCHV...
As Madrigal prepares to report its 2025 earnings, investors weigh pipeline progress, cash runway, and milestones ahea...
Nebius Group shows a dramatic jump in revenue as AI demand accelerates. This article explains the drivers, checks the...
What did Best Buy reveal about its 2026 earnings in Q4? This deep dive breaks down the numbers, drivers, and risks, p...
A disciplined, calendar-driven approach to investing is gaining ground as markets swing on tariff news and rate moves...